1. Liu, Yan, Wang, Yin, Du, Zhanwen, Zheng, Pan, Liu, Yang. 2016. Fbxo30 Regulates Mammopoiesis by Targeting the Bipolar Mitotic Kinesin Eg5. In Cell reports, 15, 1111-1122. doi:10.1016/j.celrep.2016.03.083. https://pubmed.ncbi.nlm.nih.gov/27117404/
2. Jin, Yimei, Yang, Mo, Gao, Chang, Li, Rong, Li, Mo. 2019. Fbxo30 regulates chromosome segregation of oocyte meiosis. In Cellular and molecular life sciences : CMLS, 76, 2217-2229. doi:10.1007/s00018-019-03038-z. https://pubmed.ncbi.nlm.nih.gov/30980108/
3. Yuan, Yulin, Liu, Zimeng, Li, Bohan, Zhang, Zhe, Dong, Xiao. 2023. FBXO30 functions as a tumor suppressor and an E3 ubiquitin ligase for hZIP1‑mediated HIF‑1α degradation in renal cell carcinoma. In International journal of oncology, 62, . doi:10.3892/ijo.2023.5488. https://pubmed.ncbi.nlm.nih.gov/36799168/
4. Sartori, Roberta, Schirwis, Elija, Blaauw, Bert, Amthor, Helge, Sandri, Marco. 2013. BMP signaling controls muscle mass. In Nature genetics, 45, 1309-18. doi:10.1038/ng.2772. https://pubmed.ncbi.nlm.nih.gov/24076600/
5. Cheng, Xiyue, Pei, Pei, Yu, Juan, Wang, Shan, Zhang, Ting. 2019. F-box protein FBXO30 mediates retinoic acid receptor γ ubiquitination and regulates BMP signaling in neural tube defects. In Cell death & disease, 10, 551. doi:10.1038/s41419-019-1783-y. https://pubmed.ncbi.nlm.nih.gov/31320612/
6. Yao, Yuwei, Zhang, Qi, Wei, Sitian, Zhang, Jun, Wang, Hongbo. 2024. Signature identification based on immunogenic cell death-related lncRNAs to predict the prognosis and immune activity of patients with endometrial carcinoma. In Translational cancer research, 13, 2913-2937. doi:10.21037/tcr-23-2243. https://pubmed.ncbi.nlm.nih.gov/38988945/
7. Lai, Yongxing, Lin, Han, Chen, Manli, Lin, Fan, Lin, Chunjin. 2023. Integration of bulk RNA sequencing and single-cell analysis reveals a global landscape of DNA damage response in the immune environment of Alzheimer's disease. In Frontiers in immunology, 14, 1115202. doi:10.3389/fimmu.2023.1115202. https://pubmed.ncbi.nlm.nih.gov/36895559/
智鼠故事 
